Molekule Group (Molekule Group) Debt-to-Equity : 1.16 (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Molekule Group Debt-to-Equity?

Molekule Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $4.86 Mil. Molekule Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $42.30 Mil. Molekule Group's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $40.71 Mil. Molekule Group's debt to equity for the quarter that ended in Jun. 2023 was 1.16.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Molekule Group's Debt-to-Equity or its related term are showing as below:

MKULQ' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.38 Med: 0.21 Max: 1.16
Current: 1.16

During the past 4 years, the highest Debt-to-Equity Ratio of Molekule Group was 1.16. The lowest was -0.38. And the median was 0.21.

MKULQ's Debt-to-Equity is ranked worse than
89.7% of 2621 companies
in the Industrial Products industry
Industry Median: 0.28 vs MKULQ: 1.16

Molekule Group Debt-to-Equity Historical Data

The historical data trend for Molekule Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group Debt-to-Equity Chart

Molekule Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

-0.38

0.08

Molekule Group Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Debt-to-Equity	Get a 7-Day Free Trial									-	-	0.08	0.75	1.16

Competitive Comparison of Molekule Group's Debt-to-Equity

For the Pollution & Treatment Controls subindustry, Molekule Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Molekule Group's Debt-to-Equity Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Molekule Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Molekule Group's Debt-to-Equity falls into.

Molekule Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Molekule Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.114	+	1.521)	/	19.703
	=	0.08

Molekule Group's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.86	+	42.3)	/	40.705
	=	1.16

Molekule Group (OTCPK:MKULQ) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Molekule Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Molekule Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Molekule Group (Molekule Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (OTCPK:MKULQ) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410

Website

https://www.molekule.com

Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.

Executives

Ritankar Pal	officer: Chief Operating Officer	10455 RIVERSIDE DR., PALM BEACH GARDENS FL 33410
Jonathan Harris	officer: Chief Commercial Officer	3000 CLEARVIEW WAY, SAN MATEO CA 94402
Bradley A Feld	director	C/O FOUNDRY GROUP, 645 WALNUT ST., BOULDER CO 80302
Ryan A Mcintyre	10 percent owner
Seth Levine	10 percent owner	1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Fg Next Gp, Llc	10 percent owner	1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Foundry Group Next, L.p.	10 percent owner	C/O FOUNDRY GROUP, 1050 WALNUT STREET, SUITE 219, BOULDER CO 80302
Ward Jr Stephen M	director	C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612
Timothy J Scannell	director	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Heather Floyd	director	1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Thomas P Mccaffrey	director	1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Lewis C Pell	10 percent owner	C/O VISION SCIENCES INC, 6 STRATHMORE RD, NATICK MA 01760
Michael F Senft	director	1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Jason Dibona	officer: Chief Executive Officer	10455 RIVERSIDE DRIVE, PALM BEACH GARDEN FL 33410
David Helfet	director	10455 RIVERSIDE DRIVE, PALM BEACH GARDENS FL 33410